Envista Holdings Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Envista Holdings Corporation
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- NVST
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001757073
Board of directors
-
Amir Aghdaei · Director · Chief Executive OfficerSince 2023
-
Barbara B. Hulit · DirectorSince 2023
-
Christine A. Tsingos · DirectorSince 2023
-
Daniel Raskas · DirectorSince 2023
-
James Andrew Pierce · DirectorSince 2025
-
Kieran Gallahue · DirectorSince 2023
-
Paul A. Keel · Director · Chief Executive OfficerSince 2024
-
R. Scott Huennekens · DirectorSince 2023
-
Vivek Jain · DirectorSince 2023
-
Wendy Carruthers · DirectorSince 2023
Chief executives
Paul A. Keel
· Chief Executive Officer
Since May 2024
Amir Aghdaei
· Chief Executive Officer
Until May 2024
· Former
Board connections
5 of this board's directors also sit on 9 other boards.
- via Kieran Gallahue
- via R. Scott Huennekens
- via Vivek Jain
- via R. Scott Huennekens
- via Barbara B. Hulit
- via Christine A. Tsingos
- via Barbara B. Hulit
- via R. Scott Huennekens
- via Christine A. Tsingos
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Befidi Robert Officer (President, Diagnostics) | Shares withheld for tax | −3,454 | $21.12 | $72,948 |
| Aug 25, 2025 | Hammes Eric D. Officer (Chief Financial Officer) | Shares withheld for tax | −7,654 | $21.12 | $161,652 |
| Aug 25, 2025 | Nilsson Stefan Officer (President, Nobel Biocare) | Shares withheld for tax | −804 | $21.12 | $16,980 |
| Aug 25, 2025 | Acurio Veronica Officer (President, Orthodontics) | Shares withheld for tax | −5,422 | $21.12 | $114,513 |
| Aug 25, 2025 | Reis Mischa Officer (SVP, Strategy & Bus. Dev.) | Open-market sale | −15,000 | $21.60 | $324,000 |
| Jul 14, 2025 | James Andrew Pierce Director | Grant or award | +9,155 | — | — |
| Jun 10, 2025 | Kieran Gallahue Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | Daniel Raskas Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | Vivek Jain Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | Wendy Carruthers Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | Christine A. Tsingos Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | Barbara B. Hulit Director | Grant or award | +10,450 | — | — |
| Jun 10, 2025 | R. Scott Huennekens Director | Grant or award | +14,370 | — | — |
| May 25, 2025 | Paul A. Keel Director, Officer (Chief Executive Officer) | Shares withheld for tax | −12,787 | $16.72 | $213,799 |
| Feb 26, 2025 | Reis Mischa Officer (SVP, Strategy & Bus. Dev.) | Grant or award | +8,475 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.